Far more reports are needed to advance the novel and safe treatment method of cancer-associated soreness. Incorporating interventional methods which include PNS properly can optimize The present treatment method strategy and make improvements to outcomes.These results suggest that conolidine is in a position to limit the ACKR3 receptor’s negative